Lower Risk of Chronic Diseases By helping patients lose weight and maintain a healthier BMI, semaglutide significantly reduces the risk of obesity-related conditions, including: Type 2 diabetes High blood pressure High cholesterol Sleep apnea Osteoarthritis Local healthcare professionals note that many patients experience improved lab results and reduced reliance on medications for these conditions within months of starting treatment
Available products show monthly and every-three-month savings you can manage online
At a Glance: GLP-1 Medications and Your Oral Health The Connection : Medications like Ozempic, Wegovy, and Mounjaro are changing lives, but they are also frequently linked to persistent bad breath, often called "Ozempic breath." The Science : This isn't a hygiene failure
Managing post-meal blood sugar, often called postprandial glucose control, may hold the key to better outcomes
Many patients also explore our aesthetic procedures to complement their weight loss and enhance their results